Stefano Monti PhD
Professor, Computational Biomedicine
Associate Professor, Biostatistics
75 E. Newton St | (617) 414-7031smonti@bu.edu

Sections
Computational Biomedicine
Centers
BU-BMC Cancer Center
Evans Center for Interdisciplinary Biomedical Research
Biography
Stefano Monti is a Computational Biologist and joined the BU faculty in January 2011 in the section of Computational Biomedicine, with joint appointments in the Biostatistics Department and the Bioinformatics program. Monti received his Ph.D. in Intelligent Systems and Artificial Intelligence from the University of Pittsburgh, and completed his training with a post-doctoral fellowship at the Robotics Institute at Carnegie Mellon. His doctoral and post-doctoral research focused on the development of machine learning and knowledge discovery methodologies, with a particular emphasis on probabilistic reasoning and Bayesian approaches to modeling biomedical data. Since 2001, he has worked in the field of Cancer Genomics, first as a Research Scientist at the Whitehead Institute’s Center for Genome Research, and later as a Computational Biologist in the Cancer Program at the Broad Institute.
Dr. Monti's laboratory integrates systems biology, machine learning, and bioinformatics approaches to investigate the molecular drivers of human disease, with the goals of advancing prevention and care. This multidisciplinary effort relies on the development of novel computational methodologies, and on the design of experiments based on the generation and integrative analysis of high-throughput multi-omics data, with the goal of identifying novel therapeutic targets and developing accurate diagnostic and prognostic biomarkers. Specific areas of research include the study of the molecular mechanisms of tumor initiation and progression and of the role played in it by environmental exposure, as well as the study of the biological factors contributing to healthy aging and extreme longevity.
Other Positions
Education
Artificial Intelligence, PhD, University of Pittsburgh
Artificial Intelligence, MS, University of Pittsburgh
Computer Science, MS, University of Houston
Computer Science, BS, Università degli Studi di Udine
Publications
Sebastiani P, Monti S, Lustgarten MS, Song Z, Ellis D, Tian Q, Schwaiger-Haber M, Stancliffe E, Leshchyk A, Short MI, Ardisson Korat AV, Gurinovich A, Karagiannis T, Li M, Lords HJ, Xiang Q, Marron MM, Bae H, Feitosa MF, Wojczynski MK, O'Connell JR, Montasser ME, Schupf N, Arbeev K, Yashin A, Schork N, Christensen K, Andersen SL, Ferrucci L, Rappaport N, Perls TT, Patti GJ. Metabolite signatures of chronological age, aging, survival, and longevity. Cell Rep. 2024 Nov 26; 43(11):114913. PMID: 39504246.
Published on 10/12/2024Llevenes P, Chen A, Lawton M, Qiu Y, Seen M, Monti S, Denis GV. Plasma Exosomes in Insulin Resistant Obesity Exacerbate Progression of Triple Negative Breast Cancer. bioRxiv. 2024 Oct 12. PMID: 39416125.
Published on 9/19/2024Ennis CS, Seen M, Chen A, Kang H, Ilinski A, Mahdaviani K, Ko N, Monti S, Denis GV. Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids. bioRxiv. 2024 Sep 19. PMID: 39345362.
Published on 8/13/2024Snyder M, Wang Z, Lara B, Fimbres J, Pichardo T, Mazzilli S, Khan MM, Duggineni VK, Monti S, Sherr DH. The Aryl Hydrocarbon Receptor Controls IFN?-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma. bioRxiv. 2024 Aug 13. PMID: 39185148.
Published on 7/25/2024Reed ER, Chandler KB, Lopez P, Costello CE, Andersen SL, Perls TT, Li M, Bae H, Soerensen M, Monti S, Sebastiani P. Cross-platform proteomics signatures of extreme old age. Geroscience. 2024 Jul 25. PMID: 39048883.
Published on 6/4/2024Li M, Song Z, Gurinovich A, Schork N, Sebastiani P, Monti S. yQTL Pipeline: A structured computational workflow for large scale quantitative trait loci discovery and downstream visualization. PLoS One. 2024; 19(6):e0298501. PMID: 38833463.
Published on 5/2/2024Qiu Y, Chen A, Yu R, Llevenes P, Seen M, Ko NY, Monti S, Denis GV. Insulin Resistance Increases TNBC Aggressiveness and Brain Metastasis via Adipocyte-derived Exosomes. bioRxiv. 2024 May 02. PMID: 38746141.
Published on 4/14/2024Reed ER, Chandler KB, Lopez P, Costello CE, Andersen SL, Perls TT, Li M, Bae H, Soerensen M, Monti S, Sebastiani P. Cross-platform proteomics signatures of extreme old age. bioRxiv. 2024 Apr 14. PMID: 38645061.
Published on 4/5/2024Song Z, Gunn S, Monti S, Peloso GM, Liu CT, Lunetta K, Sebastiani P. Learning Gaussian Graphical Models from Correlated Data. bioRxiv. 2024 Apr 05. PMID: 38617340.
Published on 3/7/2024Don J, Schork AJ, Glusman G, Rappaport N, Cummings SR, Duggan D, Raju A, Hellberg KG, Gunn S, Monti S, Perls T, Lapidus J, Goetz LH, Sebastiani P, Schork NJ. The relationship between 11 different polygenic longevity scores, parental lifespan, and disease diagnosis in the UK Biobank. Geroscience. 2024 Aug; 46(4):3911-3927. PMID: 38451433.
Media Mentions
Published on 10/6/2024
Making breakthroughs in fight against breast cancer
Published on 4/18/2023
Study: Strong immune cells may be the key to living to 100
Published on 4/6/2023
Immune System May Hold Secret to Living to 100
Published on 4/5/2023
New Study Finds The Key To Living To 100 And Beyond
Published on 4/5/2023
Secret To Longevity? Scientists Find Unique Immune Cells In Centenarians That Protect From Illnesses
Published on 4/5/2023
‘Elite’ Immune Systems Could Be Centenarians’ Secret: Study
Published on 4/4/2023
DNA study reveals one key factor that helps some people live beyond 100
Published on 4/4/2023
This is what you need to live to 100: DNA study
Published on 4/3/2023
A 'blueprint' for longevity: New study has an answer for why some people live to be over 100
Published on 8/10/2021
Chemicals in Your Furniture Might Impact Your Metabolism
View full list of 12 media mentions.